Our Vision and Mission Grounded in a vision of a planet protected from human suffering and the devastating social and economic consequences of COVID 19 we an initial group of global health actors BMGF CEPI Gavi Global Fund UNITAID Wellcome Trust WHO and private sector partners and other stakeholders are launching a landmark global and time limited collaboration to accelerate the development production and equitable global access to new COVID 19 essential health technologies We know that as long as anyone is at risk from this virus the entire world is at risk every single person on the planet needs to be protected from this disease We agree that alongside evidence based public health measures innovative COVID 19 diagnostics therapeutics and vaccines are needed in record time and at record scale and access to save millions of lives and countless trillions of dollars and to return the world to a sense of normalcy We recognize the significant amount of critical work investment and initiatives already ongoing around the world to expedite the development and deployment of innovative COVID 19 related products and interventions We appreciate that while development and deployment of innovative products is essential it will not be enough We must simultaneously and urgently accelerate the strengthening of sustainable health systems and capacities to enable delivery of the new COVID 19 tools to those who need them and to mitigate the knock on impact on other diseases We remember lessons from the past which have shown that even when effective tools are available to the world too often some are protected while others are not This inequity is unacceptable all tools to address COVID 19 must be available to all In the fight against COVID 19 no one should be left behind We understand we cannot do this alone and that we need to work together in unprecedented and inclusive partnership with all stakeholders political leaders public and private sector partners civil society academia and all other stakeholders across society jointly leveraging our comparative strengths and respective voices to drive towards collective solutions an accelerated path and access for all We are stronger faster and more effective working together Our Mission is not only accelerated development and availability of new COVID 19 tools it is to accelerate equitable global access to safe quality effective and affordable COVID 19 diagnostics therapeutics and vaccines and thus to ensure that in the fight against COVID 19 no one is left behind Our Commitment We commit to the shared aim of equitable global access to innovative tools for COVID 19 for all We commit to an unprecedented level of partnership proactively engaging stakeholders aligning and coordinating efforts building on existing collaborations collectively devising solutions and grounding our partnership in transparency and science We commit to create a strong unified voice to maximize impact recognizing this is not about singular decision making authority but rather collective problem solving interconnectedness and inclusivity where all stakeholders can connect and benefit from the expertise knowledge and activities of this shared action oriented platform We commit to build on past experiences towards achieving this objective including ensuring that every activity we undertake is executed through the lens of equitable global access and that the voices of the communities most affected are heard We commit to be accountable to the world to communities and to one another We are coming together in the spirit of solidarity and in the service of humanity to achieve our mission and vision Our Call We ask the global community and political leaders to support this landmark collaboration and for donors to provide the necessary resources to accelerate achievement of the objectives of this global collaboration capitalizing on the opportunity provided by the rolling pledging campaign that will start on 4 May 2020